SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001759425-24-000019
Filing Date
2024-05-08
Accepted
2024-05-08 16:16:07
Documents
82
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q mirm-20240331.htm   iXBRL 10-Q 1386175
2 EX-10.1 mirm-10qq124xexx101.htm EX-10.1 22914
3 EX-10.2 mirm-10qq124xexx102.htm EX-10.2 61075
4 EX-10.5 mirm-10qq124xexx105.htm EX-10.5 31190
5 EX-31.1 mirm-10qq124xexx311.htm EX-31.1 10570
6 EX-31.2 mirm-10qq124xexx312.htm EX-31.2 11459
7 EX-32.1 mirm-10qq124xexx321.htm EX-32.1 5193
8 EX-32.2 mirm-10qq124xexx322.htm EX-32.2 5859
14 image_1.jpg GRAPHIC 10594
  Complete submission text file 0001759425-24-000019.txt   6973629

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mirm-20240331.xsd EX-101.SCH 59249
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT mirm-20240331_cal.xml EX-101.CAL 72272
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT mirm-20240331_def.xml EX-101.DEF 264576
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mirm-20240331_lab.xml EX-101.LAB 592989
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mirm-20240331_pre.xml EX-101.PRE 425310
86 EXTRACTED XBRL INSTANCE DOCUMENT mirm-20240331_htm.xml XML 813240
Mailing Address 950 TOWER LANE, SUITE 1050 FOSTER CITY CA 94404
Business Address 950 TOWER LANE, SUITE 1050 FOSTER CITY CA 94404 650-667-4085
Mirum Pharmaceuticals, Inc. (Filer) CIK: 0001759425 (see all company filings)

IRS No.: 831281555 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38981 | Film No.: 24926320
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)